David Roman - Acutus Medical Pres CEO
| AFIBDelisted Stock | USD 0.73 0.03 3.95% |
Insider
David Roman is Pres CEO of Acutus Medical
| Age | 42 |
| Phone | 442 232 6080 |
| Web | https://www.acutusmedical.com |
David Roman Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Roman against Acutus Medical stock is an integral part of due diligence when investing in Acutus Medical. David Roman insider activity provides valuable insight into whether Acutus Medical is net buyers or sellers over its current business cycle. Note, Acutus Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Acutus Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Roman over six months ago Payment of 24086 shares by David Roman of Acutus MedicalInc subject to Rule 16b-3 |
Acutus Medical Management Efficiency
The company has return on total asset (ROA) of (0.138) % which means that it has lost $0.138 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3216) %, meaning that it created substantial loss on money invested by shareholders. Acutus Medical's management efficiency ratios could be used to measure how well Acutus Medical manages its routine affairs as well as how well it operates its assets and liabilities.Acutus Medical currently holds 38.48 M in liabilities with Debt to Equity (D/E) ratio of 0.51, which is about average as compared to similar companies. Acutus Medical has a current ratio of 5.01, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Acutus Medical's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Michael Favet | Neuropace | 54 | |
| Andrew Green | Artivion | 52 | |
| Matthew Getz | Artivion | 55 | |
| Keith Simeone | STRATA Skin Sciences | N/A | |
| Rebecca Kuhn | Neuropace | 63 | |
| Ehab Esmail | Orthofix Medical | 52 | |
| John MS | Delcath Systems | 63 | |
| Robert Moccia | STRATA Skin Sciences | 65 | |
| Joshua Wells | Artivion | N/A | |
| James Bullock | Artivion | 64 | |
| Bart Bracy | Anika Therapeutics | N/A | |
| David Colleran | Anika Therapeutics | 52 | |
| John Meduri | Accelerate Diagnostics | N/A | |
| Jean Holloway | Artivion | 63 | |
| Marshall Stanton | Artivion | 64 | |
| Rochelle Maney | Artivion | 45 | |
| Christopher Lesovitz | STRATA Skin Sciences | 41 | |
| Darrell Rigel | STRATA Skin Sciences | 73 | |
| HuiLan Wu | Ainos Inc | 63 | |
| Mark Quick | Orthofix Medical | N/A | |
| Laura Costa | Accelerate Diagnostics | N/A | |
Management Performance
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.14 |
Acutus Medical Leadership Team
Elected by the shareholders, the Acutus Medical's board of directors comprises two types of representatives: Acutus Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Acutus. The board's role is to monitor Acutus Medical's management team and ensure that shareholders' interests are well served. Acutus Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Acutus Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tom Sohn, Chief VP | ||
| Takeo Mukai, CFO CEO | ||
| Shibaji Shome, Vice Marketing | ||
| Charlie Piscitello, VP Officer | ||
| Vincent Burgess, Consultant | ||
| Gary Doherty, Senior Finance | ||
| David Roman, Pres CEO | ||
| Derrick Chou, Chief Officer | ||
| Graydon Beatty, Chief Officer |
Acutus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Acutus Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.14 | ||||
| Operating Margin | (2.89) % | ||||
| Current Valuation | 18.75 M | ||||
| Shares Outstanding | 29.72 M | ||||
| Shares Owned By Insiders | 3.15 % | ||||
| Shares Owned By Institutions | 23.50 % | ||||
| Number Of Shares Shorted | 553.6 K | ||||
| Price To Book | 0.53 X | ||||
| Price To Sales | 0.73 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Acutus Stock
If you are still planning to invest in Acutus Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acutus Medical's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |